Learning outcomes
By the end of this lesson you should be able to: identify which is sympathetic and which is parasympathetic, and what neurotransmitters they release; name the receptor subclasses (alpha-1, alpha-2, beta-1, beta-2, beta-3, muscarinic M1 to M5, nicotinic) and the main effect of each on smooth muscle, cardiac muscle, glands and metabolism; explain the difference between a directly- and an indirectly-acting sympathomimetic; give the cardiovascular actions of adrenaline and of noradrenaline and state the indication for each; list the autonomic side-effects to anticipate in a patient on a cholinergic or an antimuscarinic drug; and predict the effect of a beta-blocker in a patient with asthma.
Prerequisites
Lessons 1-5, and the physiology course's module on membrane transport and the neuromuscular junction.
The big idea
The autonomic nervous system is the body's background control: it regulates heart rate, blood pressure, gut motility, secretion, bronchi and the size of the pupil without any conscious input. It has two branches with opposing actions — sympathetic preparing the body for action, parasympathetic maintaining and conserving. Both release acetylcholine at the ganglion; the difference is what they release at the end organ, and that difference is the key to everything in this lesson.
Sympathetic versus parasympathetic
| Feature | Sympathetic | Parasympathetic |
|---|---|---|
| Preganglionic fibre length | Short (the ganglion is near the cord) | Long (the ganglion is near the target organ) |
| Preganglionic neurotransmitter | Acetylcholine, acting on nicotinic receptors | Acetylcholine, acting on nicotinic receptors |
| Postganglionic neurotransmitter | Norepinephrine, at adrenergic receptors | Acetylcholine, at muscarinic receptors |
| Exception | Sweat glands and some vessels are sympathetically cholinergic | None — the distinction is a division by transmitter |
| Overall theme | Fight, flight or freeze | Rest, digest and repair |
Remember that the postganglionic sympathetic transmitter is not always norepinephrine: sweat glands, for instance, are innervated by a sympathetic cholinergic fibre that releases acetylcholine. That is why a patient taking an anticholinergic drug, such as oxybutynin for the bladder, stops sweating, and why a cholinergic reaction, as in an acetylcholinesterase inhibitor overdose, produces profuse sweating.
Adrenergic receptors
| Receptor | Main tissue effect | Agonist | Antagonist |
|---|---|---|---|
| Alpha-1 | Vasoconstriction, contraction of the pupillary dilator and the bladder sphincter, and smooth muscle contraction in the prostate | Phenylephrine, methoxamine | Prazosin, doxazosin, tamsulosin |
| Alpha-2 | Presynaptic inhibition of transmitter release, sedation, and central sympathetic inhibition | Clonidine | Some antidepressants and opioid withdrawal agents |
| Beta-1 | Increases heart rate, contractility and conduction, and stimulates renin release | Dobutamine | Atenolol, metoprolol, bisoprolol |
| Beta-2 | Dilates bronchi, vasodilator in skeletal muscle, relaxes the uterus, and promotes hepatic glucose release | Salbutamol, salmeterol | Propranolol, but not a cardioselective blocker |
| Beta-3 | Stimulates lipolysis and detrusor relaxation | Mirabegron | Beta-blockers broadly |
NoteThe selectivity of a beta-agonist for the airway is the reason salbutamol works in asthma and the reason a beta-blocker is dangerous there: the same receptor mediates the dilation, so blocking it removes the therapeutic effect the patient may need.
Muscarinic and nicotinic receptors
| Receptor | Main tissue effect | Agonist | Antagonist |
|---|---|---|---|
| M1 | Cerebral, gastric parietal cells | Bethanechol (difficult to obtain) | Pirenzepine (limited availability) |
| M2 | Slows the heart and reduces contractility | Methacholine, acetylcholine | Atropine, glycopyrronium |
| M3 | Stimulates glandular secretion, contracts smooth muscle of the gut and bronchi, and constricts the pupil | Pilocarpine, bethanechol | Ipratropium, oxybutynin, atropine |
| Nicotinic (ganglionic) | Transmission at every autonomic ganglion | Nicotine | Hexamethonium-type ganglion blockers (historical) |
| Nicotinic (muscle) | Transmission at the neuromuscular junction | Suxamethonium, acetylcholine | Curare, pancuronium, rocuronium |
The clinical value of this table is that a patient on an antimuscarinic drug develops a predictable pattern of effects: dry mouth, blurred vision and dilated pupils, constipation and urinary retention, tachycardia, and confusion in older people. Conversely a patient on a cholinergic drug develops salivation, lacrimation, urination, diarrhoea, bradycardia, bronchoconstriction and constricted pupils — the opposite set.
Watch outThe exception that decides dosing is sweat. The sympathetic innervation of the eccrine sweat gland is cholinergic, so a cholinergic drug produces sweating and an anticholinergic drug stops it — the only situation where the two branches' actions coincide.
Worked example: the two catecholamines
Adrenaline and noradrenaline stimulate the same receptors, but they differ in relative potency, and that difference decides their clinical use. Noradrenaline acts predominantly on alpha and therefore vasoconstricts, raising blood pressure; the consequent rise in pressure increases the heart rate reflexively, and the effect is a net vasoconstrictor with a little reflex tachycardia.
| Drug | Dominant effect | Clinical indication |
|---|---|---|
| Adrenaline | Alpha and beta, with beta effects dominant at low doses: heart rate and force rise, and the bronchi and some vessels dilate | Anaphylaxis, cardiac arrest, and the addition to local anaesthetics |
| Noradrenaline | Predominantly alpha: vasoconstriction and a rise in pressure with reflex slowing | Septic shock, where peripheral vasodilation must be reversed |
| Isoprenaline | Beta-1 and beta-2: raises heart rate and dilates bronchi, but may lower the blood pressure by beta-2 vasodilation | Temporary pacing, rarely now |
| Dopamine | Dose-dependent, from dopaminergic renal vasodilation to beta and finally alpha at higher doses | Rarely now, because of the vasoconstriction to kidney and risk of arrhythmia |
Why does adrenaline relieve both the vasodilation and the bronchospasm of anaphylaxis?
Common mistakes
Watch outSaying noradrenaline acts on beta receptors primarily. It is predominantly an alpha agonist — which is why it is a vasopressor. Adrenaline is the drug with both.
Watch outSaying salbutamol will dilate the heart vessels. It is beta-2 selective and dilates bronchi and the uterus; cardiac effects come from beta-1, and salbutamol's tremor and palpitations come from activation of beta-2 in skeletal muscle rather than beta-1 at high dose.
Watch outSaying antidiuretic hormone and alpha-agonists do the same thing. They both raise the pressure, but alpha-agonists do so by direct vasoconstriction while antidiuretic hormone acts through its own receptor — and at high doses can also act at the platelet receptor.
Check your understanding
Where does the sympathetic system release acetylcholine, and why does it matter?
What would be the effect of a non-selective beta-blocker given during an anaphylactic reaction?
Why is noradrenaline used in septic shock while adrenaline is used in anaphylaxis?
Multiple choice
Which receptor is responsible for the bronchodilator effect of salbutamol?
A patient develops dry mouth, constipation, urinary retention and dilated pupils after starting a drug. What class is it?
Which is correct about the pharmacology of noradrenaline?
Which statement about the autonomic parasympathetic division is correct?
Why is a beta-blocker hazardous in a patient with asthma?
Module summary and next
The autonomic nervous system is described by its two branches — sympathetic and parasympathetic — and their neurotransmitters, which define their receptors. Adrenergic pharmacology is organised by the alpha and beta receptor subtypes, whose distribution decides their effects and their antagonists' hazards. Muscarinic receptors mediate the parasympathetic effects on target organs, with the sweat gland as the cholinergic exception on the sympathetic side. From this framework everything else follows: which drug to use in shock, which to avoid in asthma, and the entire side-effect profile of an anticholinergic prescription.
Next modules: the cardiovascular, renal, antimicrobial, and central nervous system pharmacologies, each of which is an application of the receptor framework you have now learned.